Filing Details

Accession Number:
0001493152-17-010887
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-25 17:48:30
Reporting Period:
2017-09-15
Accepted Time:
2017-09-25 17:48:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883975 Microbot Medical Inc. MBOT Biological Products, (No Disgnostic Substances) (2836) 943078125
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1690161 Moshe Shoham C/O Microbot Medical Inc.
25 Recreation Park Drive, Unit 108
Hingham MA 02043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-15 74,975 $1.25 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 28,657 $1.26 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 40,500 $1.26 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 20,276 $1.27 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 400 $1.27 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 27,384 $1.27 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 1,200 $1.28 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 14,400 $1.28 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 11,083 $1.29 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 6,463 $1.29 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 9,001 $1.30 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 6,500 $1.30 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 1,471 $1.31 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 7,490 $1.31 1,592,090 No 4 S Direct
Common Stock Disposition 2017-09-15 200 $1.32 1,592,090 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions.